Trial status
RECRUITMENT, RECRUITMENT
This is version 1.3 of the protocol, dated November 30, 2021. The first patient was randomized on December 14, 2021. Recruitment is predicted to continue until July 30, 2023. The last follow-up is expected to be completed on July 30, 2033. At the time of submission, participant recruitment is still ongoing.